Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?

Kamasak, TÜLAY; TÜREDİ, SÜLEYMAN; Serin, Hepsen; MENTEŞE, AHMET; GÜNDÜZ, ABDÜLKADİR; ALVER, AHMET; CANSU, ALİ

doi:10.3906/sag-1504-105

Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures?

Kamasak T., TÜREDİ S., Serin H. M., MENTEŞE A., GÜNDÜZ A., ALVER A., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.1, ss.282-286, 2017 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 47 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.3906/sag-1504-105
Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.282-286
Anahtar Kelimeler: Ischemia-modified albumin, generalized clonic tonic, albumin, IMA/albumin, MYOCARDIAL-ISCHEMIA, ICTAL HYPOXEMIA, MARKER, BIOMARKERS, BINDING
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Background/aim: In recent years ischemia-modified albumin (IMA) has been suggested as a marker that can be used in differentiating nonconvulsive conditions from epilepsy. The purpose of this study was to investigate changes in IMA levels caused by generalized clonic tonic (GTC) seizures.